Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Market Insight: PCSK9 Inhibitors – The Race to Become the Next New Cholesterol Block Buster

06.03.2014 / Thomson Reuters Blog

Ulrike Jahnke, Editor at Thomson Reuters, reviews the race between several pharmaceutical companies to launch the first-to-market PCSK9 inhibitor, a new class of drugs hailed the most important new heart medicines in years, with resulting multibillion-dollar sales potential. Cardiovascular disease (CVD) remains the number one killer worldwide and an estimated 23.3 million people globally will […]

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: